Study Weighs Risks and Benefits of Phase I Trials in Pediatric Cancer (IMAGE)

PLOS

Study Weighs Risks and Benefits of Phase I Trials in Pediatric Cancer

Caption

Systematic review and meta-analysis finds 1 in 10 children who enroll in pediatric phase I cancer trials are improved after the trial, and 1 in 50 die from drug-related complications

Credit

National Cancer Institute, Wikimedia

Usage Restrictions

CC0

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.